Govt orders reduction in MRP of three anti-cancer drugs

This is in pursuance to the announcement made in the Union Budget for 2024-25 exempting these three anti-cancer medicines from customs duty. The Department of Revenue has already issued a notification, reducing the custom duty to nil on these three anti-cancer drugs.